Le Lézard
Classified in: Business
Subject: ATY

Kaskela Law LLC Announces Stockholder Investigation of Otelco Inc. (OTEL) and Encourages Investors to Contact the Firm


PHILADELPHIA, July 28, 2020 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Otelco Inc. ("Otelco") (NASDAQ: OTEL) on behalf of the company's shareholders. 

On July 27, 2020, Otelco announced that it had agreed to be acquired by affiliates formed by Oak Hill Capital ("Oak Hill"), a private equity firm, for $11.75 per share in cash.  Notably, shares of Otelco's common stock closed at $12.26 per share on July 24, 2020, the trading day prior to the announced agreement with Oak Hill.

The firm's investigation seeks to determine whether Otelco stockholders (i) are expected to receive adequate consideration for their shares and (ii) are receiving all material information in connection with the proposed acquisition by Oak Hill.

Otelco shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 ? 1585, or by email at [email protected], to discuss this investigation and their legal rights and options.  Additional information may also be found at http://kaskelalaw.com/case/otelco/.

Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation.  For additional information about Kaskela Law LLC please visit www.kaskelalaw.com

CONTACT:

D. Seamus Kaskela, Esq.
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 258 ? 1585
(888) 715 ? 1740
www.kaskelalaw.com
[email protected]

This notice may constitute attorney advertising in certain jurisdictions.

SOURCE Kaskela Law LLC


These press releases may also interest you

at 16:05
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...

at 16:05
Mirum Pharmaceuticals, Inc. today reported financial results for first quarter 2024 and provided a business update. "In the first quarter, we made great progress across a number of our strategic objectives that support both the near- and long-term...

at 16:05
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, today announced its financial and operating results for the first quarter ended March 31, 2024, and provided a corporate update. "I am very pleased to announce...

at 16:05
Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today reported financial results for the first quarter ended March 31, 2024,...

at 16:05
The Trade Desk, Inc. ("The Trade Desk," the "Company" or "we") , a provider of a global technology platform for buyers of advertising, today announced financial results for its first quarter ended March 31, 2024. "Q1 was a strong quarter for The...

at 16:05
Consensus Cloud Solutions, Inc. today reported financial results for the first quarter of 2024. "I am pleased with our Q1 performance. SoHo and Corporate revenues were ahead of expectations, which combined with our cost saving measures, produced a...



News published on and distributed by: